SCHEMBL24696044

SCHEMBL24696044

CCOC(=O)c1cc2nc(CC3CCC4CCCCC4C3)cc(C(C)C)n2n1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ FAAH O00519 5/20 0.33
▸ KMT2A Q03164 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ CSNK1D P48730 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ CTSK P43235 1/20 0.31
▸ MGLL Q99685 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24696342 0.90 KDM4E (0.38) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL24695643 0.89 SMN1; SMN2 (0.39) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL24696045 0.89 ALOX5 (0.39) ALOX5KDM4EALDH1A1POLBHPGD
SCHEMBL24695973 0.89 SMN1; SMN2 (0.39) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL24696046 0.88 ALOX5 (0.39) ALOX5KDM4EALDH1A1POLBHPGD
SCHEMBL24695812 0.88 KDM4E (0.38) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL24696043 0.87 ALOX5 (0.36) ALOX5KDM4EALDH1A1POLBHPGD
SCHEMBL24696001 0.87 KDM4E (0.38) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL24696386 0.86 KDM4E (0.38) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL24696244 0.85 KDM4E (0.38) KDM4EALDH1A1POLBHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255408-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-12-08 — — WO disclosed
Send feedback